StockData
OptimizeRx Corp logo

OptimizeRx Corp (OPRX) stock

OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3030% below fair value
$6.94+0.30 (+4.52%)

Close on Nov 17, 2026Market cap $130.72MP/E 28.9Yield –

OptimizeRx price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

OptimizeRx's price to book ratio was 1.3× on Nov 11, 2026, against 2.3× a year earlier. Over the last 5 years it ranged from 0.8× to 8.7×, with a median of 1.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.3×−0.6
2025Dec 31, 20251.9×+1.1
2024Dec 31, 20240.8×−1.5
2023Dec 29, 20232.3×−0.1
2022Dec 30, 20222.4×−6.3
2021Dec 31, 20218.7×−1.4
2020Dec 31, 202010.1×+6.6
2019Dec 31, 20193.5×−4.2
2018Dec 31, 20187.6×+0.0
2017Dec 29, 20177.6×+4.6
2016Dec 30, 20163.0×−0.8
2015Dec 31, 20153.8×−1.8
2014Dec 31, 20145.7×−16.5
2013Dec 31, 201322.1×–

More OptimizeRx figures

See a number that looks wrong?